XOMA Royalty Corp. (XOMA)
25.64
-0.56
(-2.16%)
USD |
NASDAQ |
Mar 03, 16:00
25.64
0.00 (0.00%)
After-Hours: 19:06
XOMA Royalty Research and Development Expense (Annual) : 2.875M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Mirum Pharmaceuticals, Inc. | 185.83M |
| Recursion Pharmaceuticals, Inc. | 425.27M |
| Rezolute, Inc. | 61.53M |
| DiaMedica Therapeutics, Inc. | 19.06M |
| Gossamer Bio, Inc. | 137.65M |